Collectively, these findings demonstrate that CSS induces sustained increases in phosphorylated and MC1 tau, including soluble tau oligomers, in two regions with established heightened vulnerability in tauopathies, the LC and EC, and overall effect sizes on AT180, MC1, and Tau soluble oligomers are comparable for LC and EC. The gene discussed is MAPT; the disease is tauopathy.